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Abstract
Purpose of Review Sleep is an important feature in mental illness. Smartphones can be used to assess and monitor sleep, yet there
is little prior application of this approach in depressive, anxiety, or psychotic disorders. We review uses of smartphones and
wearable devices for sleep research in patients with these conditions.
Recent Findings To date, most studies consist of pilot evaluations demonstrating feasibility and acceptability of mon-
itoring sleep using smartphones and wearable devices among individuals with psychiatric disorders. Promising find-
ings show early associations between behaviors and sleep parameters and agreement between clinic-based assess-
ments, active smartphone data capture, and passively collected data. Few studies report improvement in sleep or
mental health outcomes.
Summary Success of smartphone-based sleep assessments and interventions requires emphasis on promoting long-term adher-
ence, exploring possibilities of adaptive and personalized systems to predict risk/relapse, and determining impact of sleep
monitoring on improving patients’ quality of life and clinically meaningful outcomes.
Keywords Sleep . Psychotic disorders .Mental illness . Circadian rhythms . Smartphones .Wearable
Introduction
The rapid consumer adoption of smartphones and wearables
has increased both the interest in and the feasibility of mo-
bile health across many areas of medicine. In psychiatry,
there has been an increased interest in these technologies
reflected by both growing research efforts in this area and
numerous consumer apps targetingmental health conditions
[1•]. While clinical evidence for the effectiveness of many
of these apps to aid in the diagnosis, monitoring, and ad-
junctive treatment of psychiatric conditions is limited and
lacking at present, there has been even less focus on the
ability of smartphone apps to track and promote positive
health behaviors such as sleep among persons living with
mental illness. Given the robust literature documenting the
important link between sleep and mental health, there is
potential for emerging digital technologies to concurrently
support the monitoring and tracking of mental health and
sleep with the aim of achieving improved health and well-
being for individuals living with mental illness.
In this review, we explore the current evidence on the
use of smartphones and wearables for tracking and mon-
itoring sleep in persons living with mental illness.
Specifically, we seek to summarize the state of the science
as it relates to digital interventions for sleep and mental
health and consider future research directions. We also
discuss the current shortcomings of the literature and pro-
pose solutions for using smartphone apps and wearables
to monitor sleep in patients with psychiatric disorders.
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Sleep and Psychiatric Disorders
Across all psychiatric illnesses, sleep is often both an impor-
tant clinical symptom and an important therapeutic target [2].
Sleep disturbances are also associated with lower quality of
life among patients [3]. Its importance is underscored by the
finding that sleep abnormalities in patients with psychiatric
diagnoses are associated with increased risk of suicide [4, 5].
Sleep disturbances are usually a marker for diagnosis of mood
disorders [4], and they are a risk factor for developing anxiety
and depression [6]. Moreover, insomnia can influence the tra-
jectory of depression, affecting the severity, duration, and re-
lapse rates of the disorder [7]. In psychotic disorders, sleep
disturbances are commonly associated with the prodromal
phase [8] and may be an important early marker of the
premorbid phase of the disease [9]. Sleep disturbances are also
often one of the earliest signs of relapse and decompensation
in psychotic disorders [10]. In addition, obstructive sleep ap-
nea has a high prevalence in mood and psychotic disorders
[11, 12] but is often undetected.
Patients with major depressive disorder and schizophrenia
are known to have some common sleep architecture abnor-
malities including increased sleep latency, decreased total
sleep time, and decreased sleep efficiency index [13–15]; fur-
thermore, patients with these diagnoses have lower amplitude
slow wave activity (SWA) compared to healthy controls [14].
In addition, positive and negative symptoms for schizophrenia
have been correlated with the aforementioned abnormalities.
Likewise, sleep abnormalities have been associated with bi-
polar disorder, including reduction of total sleep time in the
mania phase and increase of total sleep time in the depressive
phase, decreased rapid eye movement (REM) latency, and
increased REM density [16]. Recent research on sleep in psy-
chotic disorders has also produced new data on potential
mechanisms of illness. Studies have found that sleep spindles,
a feature of stage two non-REM sleep, which may facilitate
synaptic plasticity and memory consolidation, are reduced in
patients with schizophrenia [17, 18, 19]. Sleep spindle abnor-
malities are also associated with bipolar disorder [20] and
major depressive disorder [21].
Technology for Detecting Sleep
Abnormalities: Existing Evidence
Technology has proven valuable for supplementing the as-
sessment of sleep patterns and abnormalities in clinical set-
tings. Polysomnography (PSG), which involves recording the
biphysiological characteristics of sleep including brain waves,
eye movements, muscle activity, and heart rhythm during
sleep, is considered a gold standard for detecting sleep abnor-
malities in many psychiatric disorders [22••]. However, PSG
is not widely available or convenient for the majority of
patients. In clinical practice, sleep disturbances are often
assessed via clinical interviews. Commonly, this assessment
is based on self-reported sleep measurements, which are sus-
ceptible to recall bias and inaccuracies [23] [24]. A good ex-
ample of this phenomenon is given by Dagan et al. [25] where
the researchers found that post-traumatic stress disorder
(PTSD) patients tended to misperceive sleep problems and
found no correlation between patients’ self-reports and
actigraphy measurements for sleep duration, sleep efficiency,
activity, and number of sleep/wake transitions. Given the cog-
nitive impairment associated with psychotic disorders, and the
false beliefs linked to depressive and anxiety disorders, it is
likely that self-reported sleep symptoms may not be accurate.
Actigraphy has emerged as a more practical method for
recording patients’ circadian rhythms [26]. Actigraphs are
compact devices that allow tracking of sleep/wake patterns
for long periods of time in patient’s own environment, but
their downside is that they cannot measure sleep staging.
Despite this limitation, they are used in the clinical evalua-
tion of treatment benefits for some sleep disorders [27, 28].
Like electroencephalogram (EEG) and PSG, actigraphs
have been extensively studied [25, 27–34]. Compared to
PSG, sleep parameters measured using actigraphy can be
highly correlated in major depressive disorder and anxiety
disorders [35–37], as well as both bipolar disorder and
schizophrenia spectrum disorders [30].
Smartphones, Wearables, and New
Opportunities for Sleep Monitoring
and Intervention
Recent advances in wearables and mobile applications
have created new opportunities for symptom tracking and
intervention in psychiatry and for assessment of sleep pat-
terns [38••, 39]. Prior technologies such as PSG or
actigraphy are not part of an individual’s daily routine,
whereas smartphones are ubiquitous [40] and can yield
new opportunities to track behaviors in a non-invasive
manner. Moreover, smartphones have embedded sensors
that can facilitate data acquisition (e.g., accelerometer, mi-
crophone), offering novel opportunities to passively mon-
itor patients in their natural environments. In recent years,
studies have increasingly utilized smartphones for measur-
ing individuals’ behavior in naturalistic settings. Several of
these studies have focused on measuring different features
of sleep, such as sleep onset and wake-up time [41•], sleep
midpoint and duration [42], disruptions [43], chronotype
[44•], and activity rhythms [45] in the general population
as well as patients with psychiatric disorders [46••, 47].
In addition to sleep assessment and monitoring, today’s
smartphones have the potential to provide sleep related inter-
ventions, such as insomnia cognitive behavioral therapy
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(CBTi), and they can translate data into immediately action-
able adjunctive treatments. Thus in mood, anxiety, and psy-
chotic illnesses, where sleep disorders are often outcome pre-
dictors, highly prevalent, and associated with increased mor-
bidity and mortality—smartphones offer promising, low-cost,
accessible, and practical tools to assist with the diagnosis,
monitoring, and in some cases treatment [23, 33, 48–52]. In
the sections that follow, we summarize examples identified
from the published literature on the use of smartphones to
measure sleep parameters and interventions in patients with
depression, anxiety, and psychotic disorders.
In this report, we searched PubMed, Embase, PsycINFO,
PsycARTICLES, and Web of Science to identify recent stud-
ies using smartphones for assessment of sleep among persons
with mental illness. Specifically, we searched for original,
peer-reviewed, research articles published in English covering
three broad concepts: (1) sleep (e.g. “insomnia,” “circadian
rhythm”); (2) mobile sensing technology (e.g., “smartphone,”
“app,” “wearable,” “sensor”); and (3) mood, anxiety, and psy-
chotic disorders (e.g., “depression,” “bipolar disorder,”
“schizophrenia”). We screened around 5000 articles and con-
sidered only reports of studies that reported explicitly to have
measured sleep-related outcomes with smartphones among
patients with psychiatric disorders (e.g., major depression dis-
order, anxiety disorder, and psychotic disorders including
schizophrenia, schizoaffective, and bipolar disorders). We
did not consider any papers featuring case reports, protocols,
literature reviews, or editorials. We realize that as our process
was not systematic, there are some papers we may not have
reviewed or included here.
Evidence for Using Smartphones for Sleep
Monitoring and Intervention Among Patients
with Psychiatric Disorders
With our limited search strategy, we found eight interesting
examples using smartphones and wearable technology for
sleep tracking, monitoring, or intervention among individuals
with psychiatric disorders. Among them, six studies used dif-
ferent smartphone applications for monitoring sleep and de-
livering targeted instructional content related to sleep hygiene,
and two studies included the use of wearable devices for track-
ing sleep patterns. First, Schaffer et al. [53] performed a 6-
week open-label clinical trial to analyze the effect of
quetiapine XR for depressed patients who had not reported
improvement with an antidepressant treatment. In this study,
smartphones were used to gather daily self-reported data from
26 individuals by administering electronic versions of the 16-
item Quick Inventory of Depressive Symptoms-Self Report
(QIDS-SR) and 7-item Hospital Anxiety and Depression
Scale-Anxiety subscale (HADS-A). In addition, clinical as-
sessments were performed during weeks 1, 2, 4, and 6. The
authors found very early changes in the depressive and anxi-
ety symptoms of the subjects reported via smartphones. The
greatest change in depression symptoms was detected in the
sleep item, although it only accounted for less than one third
of the overall change.
Second, in a study by Kane et al. [54], wearable chest
sensors were used for monitoring sleep characteristics in a
group of 28 adults with bipolar disorder (n = 12) and schizo-
phrenia (n = 16) over a 4-week period. The sensors, which
were integrated with smartphones, were part of the digital
health feedback system, a networked system that acquired,
summarized, communicated, and displayed information about
medication use (ingestion), health status, and daily activities.
As part of this study, sleep duration and disruption were de-
rived from the accelerometer data collected by the wearable
sensor, while the sleep quality was self-assessed on a Likert
scale and entered into a smartphone app. Interestingly, there
were no distinguishable differences in sleep duration or dis-
ruption between bipolar and schizophrenia patients. Spearman
rank correlation coefficients, between the system-derived and
the self-reported sleep metrics, were 0.3 for duration and 0.2
for sleep disruption. The authors point out that these correla-
tions are not meaningful and highlight the well-known differ-
ences between objective and subjective measurements of
sleep in patients with depression and schizophrenia as a pos-
sible reason for the finding. The authors also suggest that
smartphones and sensors are feasible and useful for monitor-
ing changes in sleep for psychotic patients.
Third, Ben-Zeev et al. [55] employed smartphones to sup-
port psychiatric illness self-management among patients with
schizophrenia, and sleep was included as one of the targets.
The app, called FOCUS, was piloted with 33 patients over a 1-
month per iod and in par t p rov ided on-demand
psychoeducation on sleep. There were no significant changes
in patients’ beliefs about sleep difficulties or medication be-
fore and after the intervention. This outcome may be ex-
plained by the fact that the sleep intervention component of
FOCUS was not designed to provoke short-term relief but
rather to promote long-term behavior changes and manage-
ment of psychiatric symptoms, for example, by modifying
sleep hygiene. Thus, it is possible that the trial period was
too short to capture changes in sleep. In a later proof-of-
concept study, Ben-Zeev et al. utilized FOCUS-Audio/Video
(FOCUS-AV) [56], another version of the FOCUS applica-
tion, which has all the modules of FOCUS in video format.
In this study, completed over a month by nine out of ten
original participants all with schizophrenia spectrum disorder,
participants had access to videos. In these videos, a clinician
offered shortened versions of management strategies that are
normally administered during a live in-person therapy session.
Patients could access these videos on demand. On average,
patients accessed the sleep module 8.8 times throughout the
study (third rank among all modules), suggesting high interest
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in improving sleep hygiene among this group of patients.
Based on the feedback from the patients, the authors describe
these video-based interventions as usable and understandable
as well as highly engaging.
Fourth, MoodRhythm is a smartphone application de-
signed for sleep and disturbance of rhythms in affective dis-
orders [57]. In a 4-week long study [58], seven patients with
bipolar disorder were given loaner smartphones with
MoodRhythm preinstalled. Social rhythms therapy is a meth-
od used for treatment of patients with bipolar disorder in
which the stability of rhythms of daily life events is assessed
by social rhythmmetric (SRM) by self-report (pen and paper).
The MoodRhythm app uses machine learning to estimate
SRM scores from passively collected smartphone data.
Among the five social activities that SRM measures, one of
them is “out of bed” and “to bed” times. The users’ input
(SRM score) serves as the ground truth in this model. Using
this approach, the authors inferred subjects’ scores and man-
aged to distinguish between stable rhythm days (SRM ≥ 3.5)
and unstable rhythm days (SRM< 3.3) with good accuracy
(precision 0.85 and recall 0.86).
Fifth, Faurholt-Jepsen et al. [51] report on a 6-month clin-
ical trial with 61 bipolar patients using MONitoring,
treAtment and pRediCtion of bipolAr disorder episodes
MONARCA, a smartphone-based self-monitoring system,
compared to a control group without MONARCA. No statis-
tically significant correlation was found between self-reported
sleep duration and the Hamilton Depression Rating Scale
(HDRS-17) scores, although the authors report a negative cor-
relation between self-report and Young Mania Rating Scale
(YMRS) scores. A previous study on MONARCA [59•] col-
lected self-reported sleep duration but reports no results on it.
Sixth,Ben-Zeev et al. [60] andWang et al. [61•] describe a
studywith a symptom prediction system called CrossCheck,
which tracks schizophrenia symptoms based on Brief
Psychiatric Rating Scale (BPRS) in 36 recently discharged
outpatients with schizophrenia over a period of 2 to
12 months. The CrossCheck symptom prediction system
predicts the BPRS score every week based on passive
smartphone data and ecological momentary assessment
(EMA) collected over 30 days. In clinic visits, which varied
in frequency from weekly to monthly, the clinicians admin-
istered a seven-itemBPRS. The outcome of the BPRS scores
later served as the ground truthwhenpredictingBPRS scores
collected passively using the smartphone. This study is not
directly about sleep; however, different sleep parameters are
inferred frompassive data (duration, bed time, rise time) also
one of the EMA questions is “have you been sleeping well?”
which is asked three times a week. Seventh, in an 8-week
pilot study with 15 patients with schizophrenia (14 complet-
ed with varying level of adherence) conducted by Meyer
et al. [62], the aim was to use consumer wearable devices
for early detection of relapse by monitoring disturbances in
the sleep–wake cycle. In this pilot study, eachparticipantwas
given an exercise tracker (Fitbit Charge HR) and a loaner
smartphone with the Purple Robot and SleepSight apps
preinstalled. Study participants were instructed to submit
sleep diaries and answer questions about the severity of their
symptoms through SleepSight on a daily basis. These entries
served as ground truth for the passively collected data. In this
pilot study, feasibility was explored based on participants’
adherence to the technology andwearable devices, aswell as
the agreement between subjective and objective measure-
ments of sleep. Lower sleep diary completion and symptom
diary completion rates were associated with negative symp-
toms (spearman correlation with sleep diary completion ρ =
− .49, P < .05 and symptom diary completion ρ = − .40,
P < .01). Thirteen out of 14 participants met the criteria for
70% feasibility threshold for completion of the daily sleep
diary on SleepSight app, with a mean average of 91% of all
questionnaires completed. In addition, 12 out of 14 partici-
pants met the feasibility criteria for completion of the symp-
tom diary, with a mean average of 88% of filling out the
questionnaires. The authors concluded that patients with
schizophrenia show interest in sleep disturbances as an indi-
cator of relapse and that they appear willing to use consumer
wearable devices and technologies for sleep monitoring.
However, lower adherence with active monitoring towards
the end of the study suggests that passive monitoringmay be
more acceptable for patients over longer duration.
Finally, a study by Staples et al. [46••] focuses on sleep
and explores use of smartphone data for monitoring sleep
among patients with schizophrenia. In this study, 17 pa-
tients currently in treatment for schizophrenia installed the
Beiwe app on their phones, which collected passive data
continuously and EMA data three times a week. The sub-
j e c t s we re admin i s t e r ed the P i t t sbu rgh S l eep
Questionnaire Inventory (PSQI) in clinic monthly, and
the PSQI scores were then compared to the EMA and
sleep assessments based on the passive data (here, accel-
erometer data) gathered from the app. In classifying sleep
quality either as low or high, the authors report 85%
agreement between in-clinic PSQI scores and EMA data.
Estimates of sleep duration based on smartphone acceler-
ometer data were moderately correlated (r = 0.69, 95% CI
0.23–0.90) with EMA. By combining EMA data and ac-
celerometer data, the authors predicted PSQI scores for all
subjects with high accuracy (mean average error = 0.75).
Even though missing data emerged as a concern in this
study, the authors conclude that smartphone monitoring of
sleep in individuals with schizophrenia could possibly be
used for predicting in-clinic sleep metrics. In fact, it is
expected that missingness is generally a concern with pas-
sively collected smartphone data; most of the reviewed
papers may have simply ignored this problem as its
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reliable detection requires collection and analysis of raw
sensor data, as was done in this final paper.
Future Possibilities and Pitfalls
While we identified relatively few studies using smartphone
technology to monitor sleep in mood, anxiety, and psychotic
disorders, we expect that this topic will continue to gain great-
er research interest as smartphones and other consumer de-
vices become more ubiquitous. This is evident from the grow-
ing number of publications in this area in the past couple of
years. Despite the small number of studies, we can draw sev-
eral important insights from this literature. First, most of the
studies suggest that smartphones are suitable for tracking pa-
tients’ activity and could be used to find new biomarkers of
mental disorders, and some studies conclude that it is feasible
to monitor changes in sleep characteristics using wearable
sensors [46••, 54, 55, 62]. Second, smartphones are a potential
tool for collecting both passive and active data from subjects.
Passive data can be collected by means of smartphones’ em-
bedded sensors, while active data can be obtained by using a
mobile-friendly survey. Third, because most of the sensors
used for sleep monitoring are already included in
smartphones, it may not be necessary to deploy separate
wearables for gathering information solely about sleep.
For example, recent studies suggest that smartphones
can be adapted and used to measure and classify popula-
tions with sleep problems [63–65]. Importantly, we did
not encounter any studies that sought to replicate or re-
produce research results using consumer mobile technol-
ogies for sleep or any studies that reported improvement
in clinically meaningful sleep and mental health outcomes
over time, raising the need for further research.
There are also several limitations regarding what
smartphone data can tell us about sleep that require careful
consideration. For example, currently available consumer mo-
bile devices like smartphones and smartwatches are not
equippedwithmedical grade sensors. Additionally, sleep stag-
ing is not feasible at present with smartphone data alone.
Nevertheless, the ability of smartphones to track social and
behavioral markers offers a unique opportunity to better un-
derstand the complexity of mental disorders. Other valuable
data, such as duration and hours of sleep, can already be col-
lected; as the methods for inferring these and other sleep pa-
rameters improve, this approach is expected to provide impor-
tant insights into psychiatric illnesses. Overall, smartphones
can be helpful for collecting rich human behavioral data with
minimal cost if patients can use their own devices [66].
Therefore, tracking and monitoring sleep outcomes may inte-
grate seamlessly into the daily lives of individuals living with
psychiatric disorders, offering potential to yield insights about
the important relationship between sleep quality and sleep
patterns and mental health symptoms.
While current use of smartphones in this context involves
measuring sleep via self-reported surveys, new methods and
algorithms can be developed to measure sleep using passive
data, reducing the need for active user input in data collection.
Questionnaires like the PSQI can be employed to learn about
subjects’ behavioral patterns and can contribute to training
algorithms for extracting information from passive data. In
addition, simple logical rules and decision trees can be imple-
mented to infer sleep/wake status based on passive data, and
Bayesian methods can be applied to encode prior beliefs and
increase the robustness of predictions and inference [67].
Based on these observations, it seems clear that smartphones
have substantially more potential to support the monitoring of
sleep related problems than what is currently reflected in the
literature. At this time, it seems appropriate that consumer
wearable devices like smartphones and smartwatches
could augment sleep monitoring. Furthermore, increased
emphasis is needed on the potential utility of smartphone
technologies for delivering treatment interventions be-
yond active or passive symptom monitoring. For instance,
digital prompts could be tailored to patients’ needs by
leveraging real time insights collected through sleep mon-
itoring applications in order to facilitate treatment of sleep
problems and improve mental health outcomes.
External sensors are one possibility to enhance the
existing capabilities of smartphones [65] as they can be
attached to the devices, potentially improving the accura-
cy and reliabili ty of data capture. For example,
smartphone apps have been used to identify patients with
obstructive sleep apnea, a disorder that is common in pa-
tients with mood and psychotic disorders [64, 68, 69].
However, wearable sensors suffer from even lower adher-
ence and compliance than smartphone applications, and
thus, there appears to be a compromise between study
adherence and data that must be evaluated. Although the
studies summarized here reported fairly high average ad-
herence, the duration of the studies was relatively short,
with all being 6 months or less. Because of the nature of
many psychiatric illnesses, it is unclear what long-term
adherence can be expected, especially during severe
phases of mania and/or depression.
In psychiatric disorders, sleep staging including quantifica-
tion of slow wave sleep and spindles can have potential diag-
nostic and prognostic applications [15, 18]. Changes in sleep
are also early warning signs of relapse in schizophrenia or
conversion in schizophrenia prodrome. Technology is now
becoming available to use portable EEG electrodes to enable
this monitoring via smartphones [70] and other portable de-
vices [71].While further work is needed to examine feasibility
and utility of these applications, especially regarding long-
term use, their potential is promising.
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As surveys captured using smartphone technologies are a
valid form of data collection [65, 72], it is important to com-
pare smartphone-based sleep surveys with objective measure-
ment of sleep disturbances in mental disorder patients. Since
PSG is the gold standard in sleep research, it is also necessary
to examine how smartphone sensors compare to PSG in order
to understand the limitations of smartphone-based measure-
ments. For example, one recent study from the general popu-
lation compared results collected from an app versus PSG
measurements, finding that the app performed poorly [73].
However, these results do not generalize to other smartphone
apps, and given the wide variation in quality and technical
features, the performance of each app may need to be evalu-
ated individually. Kolla et al. [74••] reported on studies that
compared smartphones with PSG/actigraphy, but since most
of these studies were carried out in healthy individuals, it is
difficult to generalize those results to clinical populations.
Another potential use of smartphone technology is interven-
tion for treatment of sleep problems. By using smartphones,
interventions could be tailored to individuals’ specific symptoms
at specific times, motivating patients to use preventive strategies
while coping with real life situations and critical moments. This
alone could lead to a reduction of the intensity of the clinic-based
sections and improve the patients’ quality of life significantly
[50]. Despite FOCUS yielding promising results in the interven-
tion field, interventions related to improving sleep hygiene did
not have significant changes in the subjects’ beliefs; Ben-Zeev
et al. suggest that this might have been because of the short
duration of the trial [55] leaving the topic open for further inves-
tigation. However, since patients’ participation in active monitor-
ing may decrease drastically over time, future studies should also
aim to find the right balance between the amount of active and
passive monitoring and to find ways to encourage patients to
increase their adherence to active participation.
Smartphones can also directly deliver sleep interventions
and there is a rapidly emerging evidence for delivering CBT
insomnia [75]. Randomized trials suggest benefit in those with
self-reported symptoms of insomnia [76••] and evidence for
this modality for psychotic disorders will likely soon emerge.
Conclusions
We reviewed the use of smartphones in sleep research in
mood, anxiety, and psychotic disorder patients. We conclude
with two main observations related to the current state of the
field. First, we found limited research in the form of published
papers on this topic, perhaps due to the novelty of the topic
and approach. While there are a larger number of studies
reporting smartphone-based sleep monitoring in general pa-
tient populations, there are very few studies of digital sleep
monitoring and intervention among individuals diagnosed
with psychiatric disorders. Given the strong link between
sleep quality and mental health symptoms, this is an important
area for future investigation. Second, as this field continues to
advance rapidly, we anticipate that many more studies in the
future will make use of this approach. It is likely that there are
currently many more studies in progress that were not cap-
tured in our review. Importantly, while most of the studies in
our review were pilot studies, the findings highlight the
feasibility and acceptability of using smartphones for sub-
jective assessment and objective monitoring of sleep among
individuals with depression, anxiety, and psychotic disor-
ders. At present, smartphone technologies do not appear to
offer the quality or depth of sleep data compared to PSG,
though it is plausible that as the technology and methods
improve, new possibilities for detecting sleep problems in
individuals with psychiatric disorders will emerge.
Smartphones are ubiquitous and they offer a simple and
practical tool that may offer clinical value and utility. The
early findings summarized here are promising and empha-
size this as an important area worthy of further exploration.
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